News | May 02, 2013

eCardio Launches eCardio Verite Monitor

A single component, dual-modality remote cardiac monitor with built-in symptom and activity capture

May 2, 2013 — eCardio Diagnostics announced the launch of eCardio Verite — a patient-friendly, wireless monitor offering seamless transition between mobile cardiac telemetry and cardiac event monitoring when directed by a physician.

"We are excited to provide physicians with the innovative new choice in mobile cardiac telemetry through the launch of this monitor," said eCardio's President and Chief Executive Officer Larry Lawson. "With remote programming functionality and built-in symptom and activity capture, eCardio Verite provides physicians with the monitoring services needed to make an accurate arrhythmia diagnosis as quickly as possible."

eCardio Verite is a multi-functional monitor with both event and telemetry monitoring capabilities, including automatic detection, capturing and communication of asymptomatic events such as atrial fibrillation, bradycardia, tachycardia and cardiac pause. A remotely programmable feature of eCardio Verite allows eCardio's monitoring center to seamlessly transition the monitor from a telemetry monitor to an event monitor when directed by a patient's physician without any disruption to a patient's monitoring study.

Physicians prescribing eCardio Verite will experience additional benefits through both enhancements to existing reports and a newly developed report, the Verite Initial Assessment. The Verite Initial Assessment is provided for the first 24 hours of monitoring and may alleviate the need for preliminary Holter studies.

"Our new reports for eCardio Verite reflect what physicians have told us is desired to provide optimal care to their patients," said Lawson. "Our nationwide cardiology sales force spends time in practices every day, and those conversations played an integral part in the development of the reports we provide with this new monitor."

The enhanced reports highlight the data output from the monitor's advanced algorithm and also provide the data in organized snapshots that include a daily summary, a five-day summary and a full-study summary of each arrhythmia by type and by date.

For more information:

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init